Marc Lustig - Aug 1, 2022 Form 3 Insider Report for BriaCell Therapeutics Corp. (BCTX)

Role
Director
Signature
/s/ Marc Lustig
Stock symbol
BCTX
Transactions as of
Aug 1, 2022
Transactions value $
$0
Form type
3
Date filed
8/2/2022, 04:07 PM
Next filing
May 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BCTX Common Shares 1.64M Aug 1, 2022 See Footnote 1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BCTX Warrant Aug 1, 2022 Common Shares 20K $5.31 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Registered in the name of L5 Capital Inc, an entity controlled by the reporting person.